Treatment-Resistant Mood DisordersJay D. Amsterdam, Mady Hornig, Andrew A. Nierenberg Although antidepressants have helped millions worldwide, a substantial proportion of patients fail to respond or remit. There is little published information available to clinicians for diagnosis and management of treatment-resistant depression, causing them to make difficult decisions regarding treatment options with very limited data. The editors and their internationally distinguished team of contributors have set out to address this problem, giving a critical assessment of all aspects of treatment-resistant depression: causes, epidemiology, comorbidity, evaluation, and treatment. This timely book will be invaluable to clinicians, neuroscientists, researchers, and graduate students. |
Contents
The characterization and definition of treatmentresistant mood disorders | 3 |
Overview of treatmentresistant depression and its management | 28 |
Biological basis | 45 |
Psychoneuroendocrine aspects of treatmentresistant mood disorders | 47 |
Estrogen and depressive illness in women | 78 |
Sleep abnormalities in treatmentresistant mood disorders | 94 |
Structural and functional brain imaging in treatmentresistant depression | 109 |
Immunologic factors in treatmentresistant depression | 140 |
Cognitive therapy and psychosocial interventions in chronic and treatmentresistant mood disorders | 248 |
Special patient populations | 267 |
Chronic and refractory mood disorders in childhood and adolescence | 269 |
Treatmentresistant depression in the elderly | 284 |
Management of treatmentresistant depression during pregnancy and the postpartum period | 317 |
Preliminary algorithms for treatmentresistant bipolar depression | 346 |
Medical disorders and treatmentresistant depression | 401 |
Psychiatric comorbidity in treatmentresistant depression | 426 |
Treatment approaches | 155 |
Selective serotonin reuptake inhibitors and serotoninnorepinephrinereuptake inhibitors in treatmentresistant depression | 157 |
Conventional and second generation monoamine oxidase inhibitors in treatmentresistant depression | 178 |
Drug combination strategies | 192 |
Electroconvulsive therapy in medicationresistant depression | 219 |
Thyroid augmentation | 235 |
Suicide in treatmentrefractory depression | 473 |
Economic and ethical issues | 483 |
The economic impact of treatment nonresponse in major depressive disorders | 485 |
Ethical issues in research and treatment of patients with mood disorders | 498 |
Index | 511 |
Other editions - View all
Treatment-Resistant Mood Disorders Jay D. Amsterdam,Mady Hornig,Andrew A. Nierenberg Limited preview - 2001 |
Treatment-Resistant Mood Disorders Jay D. Amsterdam,Mady Hornig,Andrew A. Nierenberg No preview available - 2007 |
Common terms and phrases
acute adequate adolescents Affective Disorders agents alcohol American Journal Amsterdam antidepressant treatment anxiety disorders Archives associated behavior Biological Psychiatry bipolar depression bipolar disorder brain British Journal carbamazepine chronic Clinical Psychiatry Clinical Psychopharmacology clinician cognitive combination comorbid controlled cortisol decreased depressed patients depressive symptoms desipramine diagnosis disease dose double-blind drug dysthymia efficacy elderly electroconvulsive therapy estrogen fluoxetine imipramine increased inpatients Joffe Journal of Affective Journal of Clinical Journal of Psychiatry lamotrigine levels lithium augmentation major depressive disorder mania MAOIS medication metabolism mg/day monoamine oxidase inhibitors mood disorders mood stabilizers neuroleptics neurological non-response outcome personality disorders pharmacological pharmacotherapy phenelzine placebo placebo-controlled plasma potential pregnancy Psychopharmacology receptor refractory depression reported resistant depression reuptake inhibitors risk serotonin sertraline serum side effects significant sleep SSRI strategies studies suggest suicide syndrome Thase therapeutic thyroid hormone treated treatment of depression treatment-resistant depression trial tricyclic antidepressants unipolar valproate venlafaxine women
References to this book
Cognitive Therapy for Chronic and Persistent Depression Richard Moore,Anne Garland Snippet view - 2003 |